5,491
Views
10
CrossRef citations to date
0
Altmetric
Basic Research

Effects of nutritional status on acetaminophen measurement and exposure

, , , ORCID Icon, &
Pages 42-49 | Received 30 Dec 2017, Accepted 06 Jun 2018, Published online: 05 Jul 2018

References

  • Ostapowicz G, Fontana RJ, Schiødt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947–954.
  • Smilkstein MJ, Knapp GL, Kulig KW, et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med. 1988;319:1557–1562.
  • Rumack BH, Peterson RC, Koch GG, et al. Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med. 1981;141:380–385.
  • Bateman DN. Paracetamol poisoning: beyond the nomogram. Br J Clin Pharmacol. 2015;80:45–50.
  • Koppen A, van Riel A, de Vries I, et al. Recommendations for the paracetamol treatment nomogram and side effects of N-acetylcysteine. Neth J Med. 2014;72:251–257.
  • Wong A, Graudins A. Risk prediction of hepatotoxicity in paracetamol poisoning. Clin. Toxicol. 2017;1–14.
  • Hodgman MJ, Garrard AR. A review of acetaminophen poisoning. Crit Care Clin. 2012;28:499–516.
  • Kalsi SS, Dargan PI, Waring WS, et al. A review of the evidence concerning hepatic glutathione depletion and susceptibility to hepatotoxicity after paracetamol overdose. Open Access Emerg Med OAEM. 2011;3:87–96.
  • McGill MR, Jaeschke H. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res. 2013;55:879–892.
  • Price VF, Miller MG, Jollow DJ. Mechanisms of fasting-induced potentiation of acetaminophen hepatotoxicity in the rat. Biochem Pharmacol. 1987;36:427–433.
  • Walker RM, Massey TE, McElligott TF, et al. Acetaminophen toxicity in fed and fasted mice. Can J Physiol Pharmacol. 1982;60:399–404.
  • Langley SC, Kelly FJ. Differing response of the glutathione system to fasting in neonatal and adult guinea pigs. Biochem Pharmacol. 1992;44:1489–1494.
  • Hernández EÁ, Kahl S, Seelig A, et al. Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance. J Clin Invest. 2017;127:695–708.
  • van der Meer RW, Hammer S, Lamb HJ, et al. Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men. J Clin Endocrinol Metab. 2008;93:2702–2708.
  • Michaut A, Moreau C, Robin M-A, et al. Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease. Liver Int. 2014;34:e171–e179.
  • Murray M. Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis. Curr Drug Metab. 2006;7:67–81.
  • Xu J, Kulkarni SR, Li L, et al. UDP-glucuronosyltransferase expression in mouse liver is increased in obesity and fasting-induced steatosis. Drug Metab Dispos. 2012;40:259–266.
  • Darwish IA. Immunoassay methods and their applications in pharmaceutical analysis: basic methodology and recent advances. Int J Biomed Sci IJBS. 2006;2:217–235.
  • Zhang Y, Huo M, Zhou J, et al. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed. 2010;99:306–314.
  • Soeters MR, Sauerwein HP, Faas L, et al. Effects of insulin on ketogenesis following fasting in lean and obese men. Obesity (Silver Spring). 2009;17:1326–1331.
  • Meyer BH, Scholtz HE, Schall R, et al. The effect of fasting on total serum bilirubin concentrations. Br J Clin Pharmacol. 1995;39:169–171.
  • Roche. User info Cobas Integra 400/800 Acetaminophen-bilirubin interferenz. 2010.
  • Bertholf RL, Johannsen LM, Bazooband A, et al. False-positive acetaminophen results in a hyperbilirubinemic patient. Clin Chem. 2003;49:695–698.
  • Fong BM, Siu TS, Tam S. Persistently increased acetaminophen concentrations in a patient with acute liver failure. Clin Chem. 2011;57:9–11.
  • Price VF, Schulte JM, Spaethe SM, et al. Mechanism of fasting-induced suppression of acetaminophen glucuronidation in the rat. Adv Exp Med Biol. 1986;197:697–706.
  • Lammers LA, Achterbergh R, van Schaik RHN, et al. Effect of short-term fasting on systemic cytochrome p450-mediated drug metabolism in healthy subjects: a randomized, controlled, crossover study using a cocktail approach. Clin Pharmacokinet. 2017;56:1231–1244.
  • Browne TR, Szabo GK, Ajami A, et al. Performance of human mass balance studies with stable isotope-labeled drug and continuous flow-isotope ratio mass spectrometry: a progress report. J Clin Pharmacol. 1998;38:309–314.
  • Milligan TP, Morris HC, Hammond PM, et al. Studies on paracetamol binding to serum proteins. Ann Clin Biochem. 1994;31:492–496.
  • Ceelie I, James LP, Gijsen V, et al. Acute liver failure after recommended doses of acetaminophen in patients with myopathies. Crit Care Med. 2011;39:678–682.
  • Pearce B, Grant IS. Acute liver failure following therapeutic paracetamol administration in patients with muscular dystrophies. Anaesthesia. 2008;63:89–91.
  • Seifert SA, Kovnat D, Anderson VE, et al. Acute hepatotoxicity associated with therapeutic doses of intravenous acetaminophen. Clin Toxicol. 2016;54:282–285.
  • Claridge LC, Eksteen B, Smith A, et al. Acute liver failure after administration of paracetamol at the maximum recommended daily dose in adults. BMJ. 2010;341:c6764.
  • Ghose R, Omoluabi O, Gandhi A, et al. Role of high-fat diet in regulation of gene expression of drug metabolizing enzymes and transporters. Life Sci. 2011;89:57–64.
  • Achterbergh R, Lammers LA, van Nierop S, et al. A short-term high fat diet increases exposure to midazolam and omeprazole in healthy subjects. Expert Opin Drug Metab Toxicol. 2016;12:715–720.
  • Lammers LA, Achterbergh R, Pistorius MCM, et al. Quantitative method for simultaneous analysis of acetaminophen and 6 metabolites. Ther Drug Monit. 2017;39:172–179.
  • Flint RB, Mian P, van der Nagel B, et al. Quantification of acetaminophen and its metabolites in plasma using uplc-ms: doors open to therapeutic drug monitoring in special patient populations. Ther Drug Monit. 2017;39:164–171.